Blood Substitute Approved in S. Africa
JOHANNESBURG, South Africa-A new blood product that has yet to be approved in the US or Europe has been approved in South Africa.
Hemopure is made from cow hemoglobin and is the first human blood substitute. It can be kept for two years at room temperature and has been created from American cows that are seemingly disease-free. Although the manufacturing company, Biopure, says the product can be used as a substitute, doctors say it better to use Hemopure as a bridge until blood supplies are available for transfusion.
Once used, Hemopure loses its effectiveness in a day or two, requiring more transfusions. It also does not give the body platelets and plasma as donated blood does.
Biotechnology companies have been working for two decades to develop an oxygenating product. At least three other companies are in late stages of development of a similar product.
Biopure plans on filing an application for approval of Hemopure in the US and Europe this year. The company has already received approval for a different blood substitute for dogs.
Information from www.arizonarepublic.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
